Danaher (DHR) Expected to Announce Earnings on Tuesday

Danaher (NYSE:DHR) is projected to post its Q3 2025 results before the market opens on Tuesday, October 21st. Analysts expect Danaher to post earnings of $1.72 per share and revenue of $5.9972 billion for the quarter. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS.Parties may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Tuesday, October 21, 2025 at 8:00 AM ET.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping analysts’ consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. During the same period last year, the firm earned $1.72 earnings per share. Danaher’s revenue for the quarter was up 3.4% compared to the same quarter last year. On average, analysts expect Danaher to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.

Danaher Trading Down 0.8%

DHR opened at $209.14 on Monday. The company’s 50 day moving average is $201.60 and its 200-day moving average is $197.24. The company has a market cap of $149.76 billion, a P/E ratio of 44.50, a PEG ratio of 2.98 and a beta of 0.77. Danaher has a 1-year low of $171.00 and a 1-year high of $275.51. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a dividend of $0.32 per share. The ex-dividend date is Friday, September 26th. This represents a $1.28 annualized dividend and a yield of 0.6%. Danaher’s dividend payout ratio (DPR) is presently 27.23%.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on DHR. Robert W. Baird raised their price target on shares of Danaher from $229.00 to $236.00 and gave the stock an “outperform” rating in a report on Wednesday, October 15th. UBS Group reduced their price target on shares of Danaher from $240.00 to $225.00 and set a “buy” rating for the company in a research report on Wednesday, July 23rd. Evercore ISI lifted their price target on shares of Danaher from $226.00 to $245.00 and gave the company an “outperform” rating in a research report on Tuesday, October 7th. Redburn Partners set a $220.00 price target on shares of Danaher in a research report on Wednesday, October 8th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Danaher in a research report on Wednesday, October 8th. Seventeen research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $245.00.

Insiders Place Their Bets

In other news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the transaction, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 11.20% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Danaher

Several hedge funds have recently bought and sold shares of the stock. Snowden Capital Advisors LLC lifted its holdings in shares of Danaher by 0.6% during the 2nd quarter. Snowden Capital Advisors LLC now owns 9,919 shares of the conglomerate’s stock worth $1,963,000 after acquiring an additional 55 shares during the period. Gallagher Fiduciary Advisors LLC lifted its holdings in shares of Danaher by 7.5% during the 2nd quarter. Gallagher Fiduciary Advisors LLC now owns 1,149 shares of the conglomerate’s stock worth $227,000 after acquiring an additional 80 shares during the period. SkyView Investment Advisors LLC lifted its holdings in shares of Danaher by 1.6% during the 2nd quarter. SkyView Investment Advisors LLC now owns 5,174 shares of the conglomerate’s stock worth $1,029,000 after acquiring an additional 83 shares during the period. 44 Wealth Management LLC increased its position in Danaher by 7.8% during the 2nd quarter. 44 Wealth Management LLC now owns 1,264 shares of the conglomerate’s stock worth $250,000 after purchasing an additional 92 shares in the last quarter. Finally, Sivia Capital Partners LLC increased its position in Danaher by 6.3% during the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock worth $397,000 after purchasing an additional 119 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.